Sign in Subscribe
Banking industry

U.S. Stocks Decline Amid Market Volatility

Strategic Insights

— 1 min read

Tuesday's trading session saw a decline in U.S. stocks, with the S&P 500 down 0.4% and the Dow Jones Industrial Average lower by 0.7%. TheStreet's Jim Cramer, co-manager of the Action Alerts PLUS portfolio, attributed the market's weakness to its resilience in the face of a potential rate hike by the Federal Reserve.

Key Takeaways:

  • The financial sector, including Bank of America (BAC) and Citigroup (C), has been strong in recent trading, receiving positive analyst commentary.
  • Esperion Therapeutics (ESPR) has seen an 18% rally in its stock price after passing its Phase 2 trial for its cholesterol pills.
  • Cramer reminded investors to focus on companies with attractive alternatives to traditional treatments, such as Esperion's cholesterol pills.
  • The Federal Reserve's Federal Open Market Committee statement on Wednesday may shake up the markets depending on its wording about a potential rate hike.
  • Cramer warned that the market is "wearing people down" due to its tough conditions.
  • The Action Alerts PLUS portfolio, managed by Cramer and his team, aims to capitalize on these market conditions.

Statistics:

  • The S&P 500 has declined by 0.4% in Tuesday's trading session.
  • The Dow Jones Industrial Average has fallen by 0.7%.
  • Esperion Therapeutics (ESPR) stock price has seen an 18% rally after passing its Phase 2 trial.
  • The financial sector, as represented by the Financial Select Sector SPDR ETF (XLF), has been strong in recent trading.

Sources:

  • TheStreet
  • CNBC's "Stop Trading" segment
  • YCharts
  • Esperion Therapeutics (ESPR) press release (date not specified)
  • Action Alerts PLUS portfolio by TheStreet

Read more